Impact of Sofosbuvir and Daclatasvir therapy on the expression levels of inflammasomes in chronic hepatitis C infected patients

Volume 3, Issue 4, November 2022, Pages 890-898

aya fergany; Helal Hetta; Khaled Hassanein; Mohammed medhat; Gaber batiha; Asmaa S. Shaltout

• View Article
• PDF 398.41 K
• View on SCiNiTO